PubMed 22428574
Referenced in: none
Automatically associated channels: Kv7.2
Title: The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
Authors: Neil Brickel, Paul Gandhi, Kevan VanLandingham, Janet Hammond, Sarah DeRossett
Journal, date & volume: Epilepsia, 2012 Apr , 53, 606-12
PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/22428574
Abstract